PEPFAR Reauthorization: Side-by-Side of Legislation Over Time
This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief identifies time-bound PEPFAR authorities and also provides a detailed side-by-side comparison of PEPFAR’s authorizing legislation over time.
On Thursday, April 25, the Kaiser Family Foundation and the CSIS Global Health Policy Center held a policy roundtable on the latest data on funding for global health, including from the U.S. government.
After Congress provided an unprecedented level of emergency funding for Ebola in FY15 in response to the West African outbreak, beyond regular appropriations for global health programs, FY16 returned to business as usual. There was no additional emergency funding and global health amounts remained essentially flat funding compared to prior years. The FY16 Omnibus Appropriations bill, which was signed into law by the President on December 18, 2015, included an estimated $10.2 billion in funding for global health programs continuing a trend of essentially flat funding since FY10.
The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis; malaria/the President's Malaria Initiative; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health; nutrition; family planning & reproductive health; global health security; and neglected tropical diseases.
Ebola virus has a unique set of characteristics that determine how and why its spreads, and how deadly it can be. To better understand Ebola, a new Kaiser Family Foundation infographic compares it to twelve other infectious diseases that continue to represent public health challenges today and offers five key takeaways about the disease.
This budget analysis reviews U.S. funding for global health programs in the FY15 Omnibus Appropriations bill, signed into law by the President on December 16, 2014.
This report finds that funding for global malaria control and elimination activities has risen from US$871 million in 2005 to US$2.6 billion in 2013. However, total funding is significantly below US$5.1 billion, the goal set by the Global Malaria Action Plan, which is a framework endorsed by world leaders in 2008 to reach global malaria reduction targets.
Additionally, support for malaria research and development (R&D) activities in 2013 was estimated to be US$549 million, below the estimated annual need of US$750-900 million and the lowest level of funding since 2007, the first year of available data.
This Kaiser Family Foundation webinar for journalists examined President Obama's fiscal year 2015 budget request, how it will impact existing U.S. global health programs and specific countries around the globe, and how it fits into the larger foreign policy efforts of the U.S. government.
This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2014 omnibus appropriations bill signed into law on January 17, 2014. It examines funding by program area as well as trends over time.
On Wednesday, June 13, at 12:00 p.m. ET (noon), the Foundation held a live, interactive webcast to examine recent changes at the Global Fund to Fight AIDS, Tuberculosis and Malaria and the implications for U.S. global health policy.
© 2025 KFF